133 related articles for article (PubMed ID: 38497124)
21. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
22. Parathyroidectomy for Normocalcemic Tertiary Hyperparathyroidism: A 19-Year Experience.
Ramonell KM; Lindeman B; Chen H; Fazendin J
J Surg Res; 2022 Aug; 276():362-368. PubMed ID: 35429685
[TBL] [Abstract][Full Text] [Related]
23. DXA-based bone strain index in normocalcemic primary hyperparathyroidism.
Tabacco G; Naciu AM; Messina C; Sanson G; Rinaudo L; Cesareo R; Falcone S; Napoli N; Ulivieri FM; Palermo A
Osteoporos Int; 2023 May; 34(5):999-1003. PubMed ID: 36640186
[TBL] [Abstract][Full Text] [Related]
24. Renal Papillary Necrosis Associated With Normocalcemic Primary Hyperparathyroidism.
Ebrahim IC; Schmidt G; Slayden TA; Hoang TD; Shakir MKM
AACE Clin Case Rep; 2021; 7(2):113-116. PubMed ID: 34095466
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
26. [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].
Hermann M
Chirurg; 2010 May; 81(5):447-53. PubMed ID: 19468699
[TBL] [Abstract][Full Text] [Related]
27. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
28. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
29. Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism.
Naciu AM; Tabacco G; Falcone S; Incognito GG; Chiodini I; Maggi D; Pedone C; Lelli D; Bilezikian JP; Napoli N; Manfrini S; Cesareo R; Palermo A
Endocr Pract; 2021 Oct; 27(10):992-997. PubMed ID: 33962077
[TBL] [Abstract][Full Text] [Related]
30. Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype?
Khan EA; Cheddani L; Saint-Jacques C; Vargas-Poussou R; Frochot V; Chieze R; Letavernier E; Avellino V; Lionnet F; Haymann JP
J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768698
[TBL] [Abstract][Full Text] [Related]
31. Incidental Normocalcemic Primary Hyperparathyroidism Presenting With Symptomatic Hypophosphatemia: A Case Report.
Tabbikha O; Chamy J; El Khoury M
Cureus; 2023 Aug; 15(8):e44378. PubMed ID: 37779800
[TBL] [Abstract][Full Text] [Related]
32. Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.
Spivacow FR; Negri AL; del Valle EE; Fradinger E; Martinez C; Polonsky A
Int Urol Nephrol; 2012 Jun; 44(3):857-63. PubMed ID: 21505756
[TBL] [Abstract][Full Text] [Related]
33. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
34. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
35. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
[TBL] [Abstract][Full Text] [Related]
37. Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels.
Gomes SA; Lage A; Lazaretti-Castro M; Vieira JG; Heilberg IP
Braz J Med Biol Res; 2004 Sep; 37(9):1379-88. PubMed ID: 15334204
[TBL] [Abstract][Full Text] [Related]
38. Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach.
Zavatta G; Clarke BL
Endocrinol Metab (Seoul); 2021 Jun; 36(3):525-535. PubMed ID: 34107603
[TBL] [Abstract][Full Text] [Related]
39. How to manage an isolated elevated PTH?
Souberbielle JC; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2015 May; 76(2):134-41. PubMed ID: 25882890
[TBL] [Abstract][Full Text] [Related]
40. [Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].
Mogl MT; Goretzki PE
Chirurgie (Heidelb); 2023 Jul; 94(7):586-594. PubMed ID: 37291366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]